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Data on IL-10R neutralization-induced chronic colitis in Lipocalin 2
deficient mice on BALB/c background
Abstract
The data herein is related to the research article entitled “Microbiota-inducible Innate Immune, Siderophore
Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis” (Singh et al., 2016) [1] where we have
demonstrated that C57BL/6 Lipocalin 2 deficient mice (Lcn2KO) developed chronic colitis upon anti-
interleukin-10 receptor (αIL-10R) monoclonal antibody administration. In the present article, we evaluated
the susceptibility of BALB/c Lcn2KO mice and their WT littermates to the αIL-10R neutralization-induced
chronic colitis. Our data showed that αIL-10R mAb-treated BALB/c Lcn2KO mice exhibited severe chronic
colitis (i.e., splenomegaly, colomegaly, colonic pathology, and incidence of rectal prolapse) when compared to
WT mice.
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a b s t r a c t
The data herein is related to the research article entitled “Micro-
biota-inducible Innate Immune, Siderophore Binding Protein
Lipocalin 2 is Critical for Intestinal Homeostasis” (Singh et al.,
2016) [1] where we have demonstrated that C57BL/6 Lipocalin
2 deﬁcient mice (Lcn2KO) developed chronic colitis upon anti-
interleukin-10 receptor (αIL-10R) monoclonal antibody adminis-
tration. In the present article, we evaluated the susceptibility of
BALB/c Lcn2KO mice and their WT littermates to the αIL-10R
neutralization-induced chronic colitis. Our data showed that αIL-
10R mAb-treated BALB/c Lcn2KO mice exhibited severe chronic
colitis (i.e., splenomegaly, colomegaly, colonic pathology, and
incidence of rectal prolapse) when compared to WT mice.
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More speciﬁc sub-
ject area
Type of data Graphs, images, ﬁgures
How data was
acquired
Assessment of colitis parameters: splenomegaly, colomegaly, colon histology,
enzyme-linked immunosorbent assay (ELISA), and quantitative reverse-
transcription polymerase chain reaction (qRT-PCR). Biotek Eon™ microplate




Lcn2KO mice and their WT littermates were treated with anti-IL-10R mono-
clonal antibody or anti-IgG isotype control as described in Ref. [1]
Experimental
features




Data accessibility Data are provided with this article
Value of the data
 The data are valuable to researchers interested in investigating the role of lipocalin 2 (Lcn2) in
inﬂammatory bowel disease.
 The data indicate that Lcn2 deﬁciency predisposes to colitis and this phenotype can be recapitu-
lated in mice on the BALB/c background.
 The data support future studies in delineating the role of Lcn2 in conferring mucoprotection.
1. Data
The dataset of this article provides additional information to Ref. [1], in which we have char-
acterized the increased susceptibility of C57BL/6 lipocalin 2 knockout (Lcn2KO) mice to colitis. Con-
sidering that the mouse genetic background can inﬂuence colitogenesis [i.e., immune responses of
C57BL/6 and BALB/c mice are Th1 and Th2-biased, respectively [2–5], we herein investigated the
susceptibility of BALB/c Lcn2KO mice to interleukin-10 receptor (IL-10R) neutralization-induced
chronic colitis. The data presented here elucidate that the robust chronic colitis observed in αIL-
10R-treated C57BL/6 Lcn2KO mice [1] can be recapitulated in BALB/c Lcn2KO mice. Speciﬁcally,
splenomegaly, colomegaly, and elevated serum and colonic inﬂammation markers were observed in
αIL-10R-treated BALB/c Lcn2KO mice when compared to their respective WT control (Fig. 1A–E).
Remarkably, BALB/c Lcn2KO mice exhibited rectal prolapse, a severe form of colitis, upon IL-10R
neutralization (Fig. 1F). Histological analysis—extent of inﬂammatory cell inﬁltrate (ICI), epithelial
hyperplasia, goblet cell loss, and distorted crypt structure (Fig. 1G and H)— further established that
BALB/c Lcn2KO mice develop a severe chronic colitis, upon IL-10R neutralization, when compared to
WT control.
2. Experimental design, materials and methods
2.1. Mice
Lcn2KO mice [6] and their WT littermates on BALB/c background were maintained under speciﬁc-
pathogen-free conditions in the animal house facility at Pennsylvania State University, PA. Mice were
housed in cages (max. 5 mice per cage) and fed on chow-control diet ad libitum with unrestricted
access to water. Animal experiments were approved by the Institutional Animal Care and Use
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Committee (IACUC) of Pennsylvania State University. Gut microbiota composition was analyzed in
BALB/c Lcn2KO mice and their WT littermates as described in ref. [1].
2.2. IL-10R neutralization-induced chronic colitis
Four weeks old BALB/c Lcn2KO mice and their WT littermates (n¼4) were administered with four
weekly injections (1.0 mg/mouse, intraperitoneally) of anti-mouse αIL-10R mAb (BioXcell). Control
mice were administered with the isotype (IgG1) control antibody. Colonic inﬂammation was exam-
ined by monitoring for body weight, fecal occult blood, and diarrhea. At one week after the last
injection of αIL-10R mAb or IgG1 control, the mice were euthanized by CO2 asphyxiation and assessed
for standard chronic colitis parameters.
2.3. Enzyme-linked immunosorbent assay
Blood samples were collected in a BD Microtainer (Becton Dickinson) via the retro-orbital plexus
at euthanasia. Hemolysis-free sera were collected after centrifugation and stored at 80 °C until
further analysis. Serum amyloid A (SAA) level was analyzed by ELISA according to the manufacturer's
(R & D Systems) protocol.
2.4. Quantitative reverse-transcription PCR
Total RNA was isolated from colonic tissue using TRI reagent (Sigma) and used to synthesize cDNA
using the cDNA Synthesis Kit (Quanta BioSciences). qRT-PCR was performed with the use of SYBR
Green Master Mix (Quanta Bio-Sciences) and primers speciﬁc for mouse TNF and 36B4 as described in
Ref. [1], and read using the Step One Plus Real-Time PCR Q28 System (Applied Biosystems).
2.5. Histology
After euthanasia, mouse colons were prepared as Swiss roll, ﬁxed overnight in 10% neutral buf-
fered formalin and stored in 70% ethanol. Colons were processed for parafﬁn embedding and serial
sections (5 mm) were collected and stained with hematoxylin and eosin (H&E) at the Animal Diag-
nostic Laboratory, PSU. Histologic scoring was performed as described previously [7].
2.6. Statistical analysis
Data are presented as means7SEM. Statistical signiﬁcance between the groups was calculated
using a one-way ANOVA followed by Tukey's multiple comparison test. Po0.05 was considered
statistically signiﬁcant. All statistical analyses were performed with the GraphPad Prism 7.0 program
(GraphPad, Inc.).
Fig. 1. Lcn2 deﬁciency aggravates colitis upon inhibition of IL-10R signaling. Lcn2-deﬁcient mice (Lcn2KO) and WT littermates
(male, n¼4) on BALB/c background were weaned on day 21, and at four weeks of age mice were given interleukin-10 receptor
(IL-10R) neutralizing antibody (1.0 mg/mouse, 4 weekly injections; i.p., BioXcell) and monitored for body weights regularly.
Control mice received isotype control antibody (rat anti-mouse IgG1). One week post last injection, the mice were euthanized
and analyzed for colitis parameters. (A) Line graph represents percent change in body weight. (B and C) Bar graphs represent
percent (B) spleen weight and (C) colon weight. (D) Graph display circulating level of serum amyloid A (SAA), a marker of active
inﬂammation, measured by ELISA. Colons were harvested, emptied of fecal contents, opened longitudinally and washed in ice-
cold PBS. A portion of the proximal colon was collected for qPCR analysis, the remaining colon was used to make Swiss roll for
histological analysis. (E) Relative mRNA level of pro-inﬂammatory cytokines in the colon. (F) Representative colon images from
control and αIL-10R treated WT and Lcn2KO mice. Right-side panel shows the rectal prolapse (red arrow) in Lcn2KO mice.
(G) Image display hematoxylin and eosin (H&E)-stained colonic sections. Red circle shows the inﬂammatory cell inﬁltrate (ICI)
in the lamina propria and crypt architectural distortion. Black and yellow arrowhead show goblet cell loss and crypt loss
respectively. (H) Histological score was assessed by visualizing the entire H&E-stained colon sections microscopically for the
extent of ICI in lamina propria, mucosa and submucosa, epithelial hyperplasia, goblet cell loss, distorted crypt structure,
ulcerations and crypt loss. The values are expressed as mean7SEM (*po0.05).
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